News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
862,255 Results
Type
Article (87511)
Company Profile (807)
Press Release (773915)
Multimedia
Podcasts (177)
Webinars (28)
Section
Business (233088)
Career Advice (4140)
Deals (39805)
Drug Delivery (139)
Drug Development (91275)
Employer Resources (203)
FDA (18293)
Job Trends (17406)
News (397468)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (128)
Alliances (56980)
ALS (147)
Alzheimer's disease (1689)
Antibody-drug conjugate (ADC) (261)
Approvals (18328)
Artificial intelligence (508)
Autoimmune disease (98)
Automation (29)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (167)
Biotechnology (485)
Bladder cancer (138)
Brain cancer (53)
Breast cancer (519)
Cancer (4111)
Cardiovascular disease (356)
Career advice (3562)
Career pathing (38)
CAR-T (252)
CDC (57)
Cell therapy (702)
Cervical cancer (33)
Clinical research (75730)
Collaboration (1435)
Company closure (4)
Compensation (945)
Complete response letters (61)
COVID-19 (2962)
CRISPR (84)
C-suite (612)
Cystic fibrosis (140)
Data (4786)
Decentralized trials (2)
Denatured (64)
Depression (112)
Diabetes (460)
Diagnostics (7101)
Digital health (37)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (242)
Drug pricing (195)
Drug shortages (36)
Duchenne muscular dystrophy (205)
Earnings (99089)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133306)
Executive appointments (997)
FDA (20858)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1294)
Gene editing (177)
Generative AI (52)
Gene therapy (561)
GLP-1 (1031)
Government (5391)
Grass and pollen (8)
Guidances (372)
Healthcare (20938)
HIV (49)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (254)
Immuno-oncology (22)
Indications (58)
Infectious disease (3212)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (102)
Intellectual property (196)
Interviews (816)
IPO (17931)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (81)
Layoffs (643)
Leadership (37)
Legal (10148)
Liver cancer (92)
Longevity (13)
Lung cancer (591)
Lymphoma (271)
Machine learning (32)
Management (66)
Manufacturing (664)
MASH (145)
Medical device (14902)
Medtech (14928)
Mergers & acquisitions (22774)
Metabolic disorders (1179)
Multiple sclerosis (140)
NASH (23)
Neurodegenerative disease (235)
Neuropsychiatric disorders (63)
Neuroscience (2751)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (60)
Obesity (569)
Opinion (315)
Ovarian cancer (140)
Pain (171)
Pancreatic cancer (176)
Parkinson's disease (244)
Partnered (31)
Patents (427)
Patient recruitment (334)
Peanut (57)
People (66329)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23357)
Phase II (32857)
Phase III (24784)
Pipeline (2813)
Policy (300)
Postmarket research (3554)
Preclinical (10541)
Press Release (72)
Prostate cancer (204)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (696)
Real estate (7422)
Recruiting (79)
Regulatory (28106)
Reports (65)
Research institute (2694)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (140)
Series A (213)
Series B (159)
Service/supplier (30)
Sickle cell disease (81)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (41)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (111)
Vaccines (1059)
Venture capital (67)
Weight loss (402)
Women's health (60)
Worklife (21)
Date
Today (201)
Last 7 days (839)
Last 30 days (2973)
Last 365 days (33505)
2025 (27791)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1282)
Alabama (80)
Alaska (7)
Arizona (307)
Arkansas (14)
Asia (51052)
Australia (8976)
California (9743)
Canada (2916)
China (939)
Colorado (411)
Connecticut (432)
Delaware (279)
Europe (117304)
Florida (1437)
Georgia (321)
Hawaii (3)
Idaho (67)
Illinois (826)
India (55)
Indiana (481)
Iowa (20)
Japan (335)
Kansas (126)
Kentucky (39)
Louisiana (22)
Maine (78)
Maryland (1306)
Massachusetts (7292)
Michigan (318)
Minnesota (578)
Mississippi (4)
Missouri (124)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (80)
New Jersey (2707)
New Mexico (32)
New York (2638)
North Carolina (1429)
North Dakota (10)
Northern California (4459)
Ohio (308)
Oklahoma (22)
Oregon (51)
Pennsylvania (2018)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (51)
South Dakota (1)
Southern California (3715)
Tennessee (152)
Texas (1533)
United States (35891)
Utah (292)
Virginia (253)
Washington D.C. (84)
Washington State (835)
West Virginia (4)
Wisconsin (100)
Wyoming (1)
There are 862,255 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
AbbVie’s Immunology Dyad Dominates Again in Q3
Skyrizi and Rinvoq sold nearly seven billion dollars, almost half of the company’s income for the quarter alone.
October 31, 2025
·
2 min read
·
Dan Samorodnitsky
Deals
4DMT Sends Eye Disease Asset’s Asia Rights to Otsuka for $85M Upfront
Otsuka Pharmaceuticals could shell out over $400 million in total for the Asia-Pacific rights to 4D-150, which combines a VEGF-C inhibitory RNAi with Regeneron’s Eylea into a single ocular injection.
October 31, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Gilead Sciences Wins Prestigious 2025 Prix Galien USA Award for Best Pharmaceutical Product With Yeztugo® (Lenacapavir)
October 31, 2025
·
11 min read
Press Releases
Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
October 31, 2025
·
1 min read
Press Releases
InterVene Receives FDA 510(k) Clearance for Recana®, the First Fully Integrated Thrombectomy System for Venous In-Stent Restenosis and Native Vessel Obstructions
October 31, 2025
·
2 min read
Press Releases
Zai Lab Announces Participation in Investor Conferences in November and December 2025
October 31, 2025
·
1 min read
Press Releases
Stevanato Group to Participate in Upcoming November 2025 Investor Conferences
October 31, 2025
·
1 min read
Press Releases
Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025
October 31, 2025
·
1 min read
Press Releases
Overall Survival Data from HARMONi-A, Featuring Ivonescimab in Combination with Chemotherapy vs. Chemotherapy in 2L+ Treatment of Patients with EGFRm NSCLC in China, to be Showcased at SITC 2025
October 31, 2025
·
10 min read
Press Releases
Sensient Technologies Corporation Reports Results for the Quarter Ended September 30, 2025
October 31, 2025
·
17 min read
1 of 86,226
Next
